Global Aspergillosis Treatment Market Size & Outlook
Global aspergillosis treatment market, 2018-2030 (US$M)
Related Markets
Global aspergillosis treatment market highlights
- An overview of the global aspergillosis treatment market trends heading towards 2030. The global market generated a revenue of USD 4,251.1 million in 2022 and is expected to reach USD 5,785.4 million by 2030.
- The overall growth of the global market from 2022 to 2030. The market is expected to grow at a CAGR (2023 - 2030) of 3.9% to attain a revenue of USD 5,785.4 million by 2030.
- A look at the global market revenues per segment in 2022. In terms of segment, allergic aspergillosis accounted for a revenue of USD 2,086.0 million in 2022.
- The segment witnessing the fastest revenue growth within the market. Chronic Aspergillosis is the most lucrative type segment registering the fastest growth during the forecast period.
- An overview of global market per region and country. In terms of region, North America was the largest revenue generating market in 2022. Country-wise, Spain is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 4,251.1 million |
| Market revenue in 2030 | USD 5,785.4 million |
| Growth rate | 3.9% (CAGR from 2022 to 2030) |
| Largest segment | Allergic aspergillosis |
| Fastest growing segment | Chronic Aspergillosis |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allergic Aspergillosis, Chronic Aspergillosis, Invasive Aspergillosis |
Other key industry trends
- In terms of revenue, the North America accounted for 41.2% of the global aspergillosis treatment market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Spain is the fastest growing regional market and is projected to reach USD 84.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aspergillosis Treatment Market Scope
Aspergillosis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Pulmatrix Inc | View profile | 22 | 36 Crosby Drive, Suite 100, Bedford, MA, United States, 01730 | https://www.pulmatrix.com |
| Mayne Pharma Group Ltd | View profile | 160 | 1538 Main North Road, Salisbury South, Salisbury, SA, Australia, 5106 | http://www.maynepharma.com |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global aspergillosis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aspergillosis treatment market will help companies and investors design strategic landscapes.
Allergic aspergillosis was the largest segment with a revenue share of 49.07% in 2022. Horizon Databook has segmented the Global aspergillosis treatment market based on allergic aspergillosis, chronic aspergillosis, invasive aspergillosis covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Aspergillosis Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Invasive Aspergillosis
- Allergic Aspergillosis
- Chronic Aspergillosis
- Global Aspergillosis Treatment Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Other Drug Class
- Antifungal Drugs
- Polyenes
- Azoles
- Echinocandins
- Other Antifungal Drugs
- Allylamines
- Global Aspergillosis Treatment Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral Drugs
- Other Route of Administrations
- Ointments
- Powders
- Global Aspergillosis Treatment Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Other Distribution Channels
- Hospital Pharmacy
- Retail Pharmacy
Reasons to subscribe to Global aspergillosis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global aspergillosis treatment market databook
-
Our clientele includes a mix of aspergillosis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global aspergillosis treatment market, including forecasts for subscribers. This global databook contains high-level insights into Global aspergillosis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global aspergillosis treatment market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Aspergillosis treatment market report size, 2022 (US$M)
Global aspergillosis treatment market report share, by route of administration, 2022 & 2030 (%, US$M)
Aspergillosis treatment market: Opportunity assessment by country
Global aspergillosis treatment market, by region, 2022 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
